Materiały źródłowe

• #1 COVID-19 Vaccines | HHS.govLock

  https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html

  COVID-19 vaccines are safe and effective. […] Getting vaccinated is the best way to help protect people from COVID-19. […] The federal government has been working since the pandemic started to develop, manufacture, and distribute safe and effective COVID-19 vaccines. […] The Food and Drug Administration (FDA) reviews and evaluates COVID-19 vaccines for quality, safety, and effectiveness. […] The FDA determines that these vaccines are safe and effective for public use. […] After the FDA authorizes the emergency use of a vaccine, an independent panel of medical and health experts called the Advisory Committee on Immunization Practices (ACIP) provides recommendations and guidance to the Director of the Centers for Disease Control and Prevention (CDC) regarding the use of the vaccine.

• #2

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  COVID-19 vaccines are safe. […] Safe and effective vaccines help ensure that COVID-19 does not result in severe disease and death. In 2021 alone, COVID-19 vaccines saved at least an estimated 14.4 million lives worldwide. […] The table below outlines the updated recommendations based on a persons (1) vaccination history and (2) age and health condition. Summary SAGE recommendations for COVID-19 vaccine […] Revaccination approximately 12 months after the previous dose is particularly important for those groups at higher risk of severe disease and mortality (older adults, people with chronic diseases, pregnant persons, immunocompromised persons) and health workers. […] Take whatever vaccine is made available to you, even if you have already had COVID-19. Hybrid immunity (protection from both vaccination and COVID-19 infection) enhances protection against severe disease of future COVID-19 infections and confers longer protection.

• #3 COVID-19 Vaccine

  https://www.sandiegocounty.gov/content/sdc/hhsa/programs/phs/community_epidemiology/dc/2019-nCoV/vaccines.html

  Currently, there are 2 types of COVID-19 vaccines for use in the United States: mRNA (Pfizer-BioNTech or Moderna) […] Protein subunit vaccines (Novavax). […] Side effects are a sign that the vaccine is working. […] All steps were taken to ensure COVID-19 vaccine safety and effectiveness, including: Clinical Trials All vaccines in the United States must go through three phases of clinical trials to ensure they are safe and effective. […] Before vaccines are available to people, the U.S. Food and Drug Administration (FDA) reviews data from clinical trials. […] COVID-19 vaccines continue to be monitored for safety and effectiveness. […] Hundreds of millions of people in the United States have safely received COVID-19 vaccines.

• #4 COVID-19: Vaccines – UpToDate

  https://www.uptodate.com/contents/covid-19-vaccines

  COVID-19 vaccines are considered the most promising approach for curbing the coronavirus disease 2019 (COVID-19) pandemic. Several COVID-19 vaccines are available globally. […] The World Health Organization (WHO) maintains an updated list of vaccine candidates under evaluation and available for administration. […] Vaccines to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are considered the most promising approach for curbing the coronavirus disease 2019 (COVID-19) pandemic. […] Each vaccine that has received emergency use listing by the World Health Organization (WHO; which includes those that have been authorized or approved in the United States) has gone through the standard preclinical and clinical stages of development. […] Safety criteria have remained stringent; data safety and monitoring committees (DSMCs) composed of independent vaccine experts and study sponsors assess adverse events that are reported in each phase of clinical study and must give approval before a candidate vaccine can advance to the next phase of evaluation. […] Vaccine efficacy in percent is defined as the reduction in disease incidence among those who received vaccine versus those who received the control product.

• #5 Different types of COVID-19 vaccines: How they work

  https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/different-types-of-covid-19-vaccines/art-20506465

  COVID-19 vaccines lower your risk of getting sick, seriously ill or dying from the disease. […] Each COVID-19 vaccine causes the immune system to create proteins called antibodies. […] This causes the body to create antibodies. Then if you catch the COVID-19 virus, these antibodies are used to help clear out the virus. […] Once the immune system recognizes the S proteins, it creates antibodies and defensive white blood cells. If infection with the COVID-19 virus happens later, the antibodies help clear out the virus. […] Getting vaccinations as they are updated and on schedule gives you the best protection against COVID-19.

• #6 COVID-19 Vaccine

  https://www.sandiegocounty.gov/content/sdc/hhsa/programs/phs/community_epidemiology/dc/2019-nCoV/vaccines.html

  COVID-19 can cause severe illness or death. You can also continue to have long-term health issues after infection. Getting the COVID-19 vaccine is a safe and dependable way to build immunity to COVID-19 without having to get the illness. Vaccination can reduce your risk of hospitalization or death from COVID-19. […] Different types of vaccines work in different ways to provide protection. […] All COVID-19 vaccines prompt our bodies to recognize and help protect us from the virus that causes COVID-19. […] None of these vaccines can give you COVID-19. […] Vaccines do not use any live virus. […] Vaccines cannot cause infection with the virus that causes COVID-19 or other viruses. […] Sometimes after vaccination, the process of building immunity can cause symptoms, such as fever. These symptoms are normal signs the body is building immunity.

• #7 Comparing the COVID-19 Vaccines: How Are They Different? > News > Yale Medicine

  https://www.yalemedicine.org/news/covid-19-vaccine-comparison

  COVID-19 is now in its fifth year, and the subvariants of the Omicron strain continue to drive infections in the United States. The good news is that vaccines, which have been updated each year since 2022, are still expected to be effective at preventing severe disease, hospitalization, and death from COVID. […] In the U.S., infants, children, and adults ages 6 months and older are eligible to be vaccinated, according to the Centers for Disease Control and Prevention (CDC). […] The 2024-2025 updated vaccines were approved based on preclinical studies of their efficacy against circulating strains. People may still become infected even though they have been vaccinated, but the goal of the vaccines now is to prevent severe disease, hospitalization and death. […] Research has suggested that people who are infected after vaccination also are less likely to report Long COVID (defined as signs, symptoms, and conditions that continue or develop after acute COVID infection), compared to those who were not vaccinated.

• #8 COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in eight European countries in the VEBIS monitoring network – October 2023 to April 2024

  https://www.ecdc.europa.eu/en/publications-data/covid-19-vaccine-effectiveness-hospitalisation–death-health-records

  This document reports the results of prospective monitoring of COVID-19 vaccine effectiveness. […] The effectiveness of the monovalent XBB.1.5 COVID-19 vaccine dose against hospitalisation due to COVID-19 for the first eight-week observation window (from the start of the campaigns in October to 25 November 2024) was 65% (95%CI: 56 to 71) and 64% (95%CI: 55 to 72) among the population aged 80 and 65-79 years, respectively. Vaccine effectiveness against COVID-19-related death was 67% (95%CI: 41 to 81) and 67% (95%CI: 43 to 81) among the population aged 80 and 65-79 years, respectively. […] Overall, the results of this study indicate that the 2023 autumnal dose was effective in restoring protection against hospitalisation and COVID-19-related death. However, VE declined over time and reached 55% for both outcomes and age groups after January 2024.

• #9 Early effectiveness of the BNT162b2 KP.2 vaccine against COVID-19 in the US Veterans Affairs Healthcare System | Nature Communications

  https://www.nature.com/articles/s41467-025-59344-7

  This test-negative case-control study within the US Veterans Affairs Healthcare System aims to estimate early vaccine effectiveness (VE) of the BNT162b2 KP.2 vaccine (20242025 formulation) compared to not receiving the KP.2 vaccine against COVID-19 outcomes. […] Overall, adjusted VE of the BNT162b2 KP.2 vaccine (compared to not receiving a KP.2 strain-adapted vaccine of any kind) against all COVID-19 outcomes was 56% (95% CI: 4863%). Adjusted VE estimates by outcome were 68% (4282%), 57% (4665%), and 56% (3669%) against hospitalizations, ED/UC visits, and outpatient visits, respectively. […] Our study is among the first to present early COVID-19 VE data for the 20242025 viral respiratory season. Results suggest that the BNT162b2 KP.2 vaccine provided significant protection against both mild and severe COVID-19 outcomes during the early part of the season. VE against milder outpatient disease (ED/UC or outpatient visits) was 5657% and against hospitalization was 68%.

• #10 COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in eight European countries in the VEBIS monitoring network – October 2023 to April 2024

  https://www.ecdc.europa.eu/en/publications-data/covid-19-vaccine-effectiveness-hospitalisation–death-health-records

  This document reports the results of prospective monitoring of COVID-19 vaccine effectiveness. […] The effectiveness of the monovalent XBB.1.5 COVID-19 vaccine dose against hospitalisation due to COVID-19 for the first eight-week observation window (from the start of the campaigns in October to 25 November 2024) was 65% (95%CI: 56 to 71) and 64% (95%CI: 55 to 72) among the population aged 80 and 65-79 years, respectively. Vaccine effectiveness against COVID-19-related death was 67% (95%CI: 41 to 81) and 67% (95%CI: 43 to 81) among the population aged 80 and 65-79 years, respectively. […] Overall, the results of this study indicate that the 2023 autumnal dose was effective in restoring protection against hospitalisation and COVID-19-related death. However, VE declined over time and reached 55% for both outcomes and age groups after January 2024.

• #11 COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in eight European countries in the VEBIS monitoring network – October 2023 to April 2024

  https://www.ecdc.europa.eu/en/publications-data/covid-19-vaccine-effectiveness-hospitalisation–death-health-records

  This document reports the results of prospective monitoring of COVID-19 vaccine effectiveness. […] The effectiveness of the monovalent XBB.1.5 COVID-19 vaccine dose against hospitalisation due to COVID-19 for the first eight-week observation window (from the start of the campaigns in October to 25 November 2024) was 65% (95%CI: 56 to 71) and 64% (95%CI: 55 to 72) among the population aged 80 and 65-79 years, respectively. Vaccine effectiveness against COVID-19-related death was 67% (95%CI: 41 to 81) and 67% (95%CI: 43 to 81) among the population aged 80 and 65-79 years, respectively. […] Overall, the results of this study indicate that the 2023 autumnal dose was effective in restoring protection against hospitalisation and COVID-19-related death. However, VE declined over time and reached 55% for both outcomes and age groups after January 2024.

• #12 Comparing the COVID-19 Vaccines: How Are They Different? > News > Yale Medicine

  https://www.yalemedicine.org/news/covid-19-vaccine-comparison

  COVID-19 is now in its fifth year, and the subvariants of the Omicron strain continue to drive infections in the United States. The good news is that vaccines, which have been updated each year since 2022, are still expected to be effective at preventing severe disease, hospitalization, and death from COVID. […] In the U.S., infants, children, and adults ages 6 months and older are eligible to be vaccinated, according to the Centers for Disease Control and Prevention (CDC). […] The 2024-2025 updated vaccines were approved based on preclinical studies of their efficacy against circulating strains. People may still become infected even though they have been vaccinated, but the goal of the vaccines now is to prevent severe disease, hospitalization and death. […] Research has suggested that people who are infected after vaccination also are less likely to report Long COVID (defined as signs, symptoms, and conditions that continue or develop after acute COVID infection), compared to those who were not vaccinated.

• #13 The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10644173/

  We performed a systematic literature review and meta-analysis on the effectiveness of coronavirus disease 2019 (COVID-19) vaccination against post-COVID conditions (long COVID) among fully vaccinated individuals. […] The pooled DOR for post-COVID conditions among fully vaccinated individuals was 0.680 (95% CI: 0.5230.885) with an estimated VE of 32.0% (11.5%47.7%). Vaccine effectiveness was 36.9% (23.1%48.2%) among those who received two doses of COVID-19 vaccine before COVID-19 infection and 68.7% (64.7%72.2%) among those who received three doses before COVID-19 infection. […] Receiving a complete COVID-19 vaccination prior to contracting the virus resulted in a significant reduction in post-COVID conditions throughout the study period, including during the Omicron era. Vaccine effectiveness demonstrated an increase when supplementary doses were administered.

• #14

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  COVID-19 vaccines are safe. […] Safe and effective vaccines help ensure that COVID-19 does not result in severe disease and death. In 2021 alone, COVID-19 vaccines saved at least an estimated 14.4 million lives worldwide. […] The table below outlines the updated recommendations based on a persons (1) vaccination history and (2) age and health condition. Summary SAGE recommendations for COVID-19 vaccine […] Revaccination approximately 12 months after the previous dose is particularly important for those groups at higher risk of severe disease and mortality (older adults, people with chronic diseases, pregnant persons, immunocompromised persons) and health workers. […] Take whatever vaccine is made available to you, even if you have already had COVID-19. Hybrid immunity (protection from both vaccination and COVID-19 infection) enhances protection against severe disease of future COVID-19 infections and confers longer protection.

• #15

  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines

  Hybrid immunity the immunity one receives from both vaccination and prior COVID-19 infection enhances protection against the severe outcomes of future COVID-19 infections and offers longer protection than infection alone. […] Yes, WHO recommends a single dose of the COVID-19 vaccine during each pregnancy. Pregnant persons are at a higher risk from COVID-19, which can affect both them and the baby. […] Vaccination during pregnancy is safe. It also benefits the baby, as it allows the antibodies created to be passed from mother to child. These antibodies can also help protect the baby for the first few months of life. […] Yes, you should get vaccinated if you are planning to get pregnant. […] There is no evidence that suggests the COVID-19 vaccines interfere with fertility. There is currently no biological evidence that antibodies from COVID-19 vaccination or vaccine ingredients could cause any problems with reproductive organs. […] If you are breastfeeding, you should get vaccinated against COVID-19 with the available vaccine according to your national recommendations.

• #16 FDA Authorizes COVID Drug Pemgarda for High-Risk Patients > News > Yale Medicine

  https://www.yalemedicine.org/news/new-covid-drug-pemgarda

  A Yale Medicine expert explains the significance of a new pre-exposure prophylaxis (PrEP) medication to protect immunocompromised people against COVID-19. The Food and Drug Administration (FDA) granted an emergency use authorization (EUA) to a medicine meant to protect certain immunocompromised people against COVID-19. This medication provides important protection for the immunocompromised, a population that is more likely to have serious COVID illness and a higher mortality rate, says Scott Roberts, MD, a Yale Medicine infectious diseases specialist. For these patients, the pandemic is not over, says Dr. Roberts. Hopefully, this new treatment will help the vulnerable feel safer. […] Vaccination is still the best tool we have to offer for the prevention of severe COVID. However, this drug is a new tool that can help immunocompromised patients feel safe going about daily activities as many other people do at this phase of the pandemic, he adds.

• #17 Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals | FDA

  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure

  Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZenecas Evusheld (tixagevimab co-packaged with cilgavimab and administered together) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and pediatric individuals (12 years of age and older weighing at least 40 kilograms [about 88 pounds]). […] Vaccines have proven to be the best defense available against COVID-19. However, there are certain immune compromised individuals who may not mount an adequate immune response to COVID-19 vaccination, or those who have a history of severe adverse reactions to a COVID-19 vaccine and therefore cannot receive one and need an alternative prevention option, said Patrizia Cavazzoni, M.D., director of the FDAs Center for Drug Evaluation and Research. Todays action authorizes the use of the combination of two monoclonal antibodies to reduce the risk of developing COVID-19 in these individuals.

• #18 FDA Authorizes COVID Drug Pemgarda for High-Risk Patients > News > Yale Medicine

  https://www.yalemedicine.org/news/new-covid-drug-pemgarda

  Pemgarda is a type of medicine called pre-exposure prophylaxis (PrEP), which is taken to prevent COVID infection. Pemgarda serves as a tool to increase SARS-CoV-2-specific antibodies to levels seen in nonimmunocompromised individuals after vaccination, says Dr. Roberts. […] Pemgarda is the only COVID PrEP drug on the market. […] In trials, adintrevimab was associated with an approximate 70% risk reduction of developing symptomatic COVID-19 compared to a placebo, according to Invivyd, the company that makes the drug.

• #19 STAY PrEPARED: Understanding COVID-19 Pre-Exposure Prophylaxis

  https://www.contagionlive.com/view/stay-prepared-understanding-covid-19-pre-exposure-prophylaxis

  COVID-19 and Immunocompromised Individuals On May 5, 2023, the World Health Organization declared an end to the global health emergency phase of COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. The development of effective COVID-19 vaccines was paramount to the pandemic response, protecting against severe disease while helping to reduce new outbreaks of the virus. However, patients with compromised immune systems may be unable to receive adequate protection from the latest vaccinations and remain at risk of severe disease, owing to suboptimal antibody response and inadequate levels of SARS-CoV-2 neutralizing antibodies following vaccination. […] Monoclonal antibodies are synthetic proteins that mimic the immune systems ability to fight off pathogens such as the SARS-CoV-2 virus. AntiSARS-CoV-2 monoclonal antibodies have been utilized as prophylactic agents for COVID-19 in individuals with moderate to severe immune compromise. […] Currently, pemivibart is the only monoclonal antibody agent authorized for PrEP of COVID-19. As new SARS-CoV-2 variants continue to emerge, it is essential to evaluate pemivibart’s effectiveness against new variants.

• #20 Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals | FDA

  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure

  Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZenecas Evusheld (tixagevimab co-packaged with cilgavimab and administered together) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and pediatric individuals (12 years of age and older weighing at least 40 kilograms [about 88 pounds]). […] Vaccines have proven to be the best defense available against COVID-19. However, there are certain immune compromised individuals who may not mount an adequate immune response to COVID-19 vaccination, or those who have a history of severe adverse reactions to a COVID-19 vaccine and therefore cannot receive one and need an alternative prevention option, said Patrizia Cavazzoni, M.D., director of the FDAs Center for Drug Evaluation and Research. Todays action authorizes the use of the combination of two monoclonal antibodies to reduce the risk of developing COVID-19 in these individuals.

• #21 Evusheld (formerly AZD7442) long-acting antibody combination authorised for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19

  https://www.astrazeneca.com/media-centre/press-releases/2021/evusheld-long-acting-antibody-combination-authorised-for-emergency-use-in-the-us-for-pre-exposure-prophylaxis-prevention-of-covid-19.html

  AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation (EUA) in the US for the pre-exposure prophylaxis (prevention) of COVID-19, with first doses expected to become available very soon. […] The Food and Drug Administration (FDA) granted the EUA for Evusheld for pre-exposure prophylaxis of COVID-19 in adults and adolescents (aged 12 and older who weigh 40kg or more) with moderate to severe immune compromise due to a medical condition or immunosuppressive medications and who may not mount an adequate immune response to COVID-19 vaccination, as well as those individuals for whom COVID-19 vaccination is not recommended. […] We are proud to play a leading role in fighting the COVID-19 pandemic and, with Evusheld, we now have the first antibody therapy authorised in the US to prevent COVID-19 symptoms before virus exposure, while also providing long lasting protection with a single dose.

• #22 Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals | FDA

  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure

  Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZenecas Evusheld (tixagevimab co-packaged with cilgavimab and administered together) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and pediatric individuals (12 years of age and older weighing at least 40 kilograms [about 88 pounds]). […] Vaccines have proven to be the best defense available against COVID-19. However, there are certain immune compromised individuals who may not mount an adequate immune response to COVID-19 vaccination, or those who have a history of severe adverse reactions to a COVID-19 vaccine and therefore cannot receive one and need an alternative prevention option, said Patrizia Cavazzoni, M.D., director of the FDAs Center for Drug Evaluation and Research. Todays action authorizes the use of the combination of two monoclonal antibodies to reduce the risk of developing COVID-19 in these individuals.

• #23 Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients—A Tailored Approach Based on SARS-CoV-2 Vaccine Response

  https://www.mdpi.com/2076-393X/12/8/871

  Patients with hematologic malignancies still face a significant risk of severe coronavirus disease 2019 (COVID-19). […] The intramuscular combination Tixagevimab/Cilgavimab (TIX/CGB) was approved by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) in December 2021 and March 2022 as a primary pre-exposure prophylaxis (PrEP) in immunocompromised patients. […] The German national guidelines recommended TIX/CGB PrEP should only be given to patients who remained seronegative after full vaccination and/or infection. […] Our real-world study in a hematologic patient population, which was treated following these guidelines, showed that administration of TIX/CGB PrEP to this highly vulnerable group of seronegative patients resulted in a similar rate of SARS-CoV-2 breakthrough infections and COVID-19 severity compared to a seropositive control group. […] Our results support the SARS-CoV-2 nAB status-based tailored approach of administering TIX/CGB PrEP to seronegative patients.

• #24 Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals | FDA

  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure

  One dose of Evusheld, administered as two separate consecutive intramuscular injections (one injection per monoclonal antibody, given in immediate succession), may be effective for pre-exposure prevention for six months. […] Pre-exposure prevention with Evusheld is not a substitute for vaccination in individuals for whom COVID-19 vaccination is recommended. […] The FDA has approved one vaccine and authorized others to prevent COVID-19 and serious clinical outcomes associated with a COVID-19 infection, including hospitalization and death. […] The agency has also determined that the known and potential benefits of Evusheld, when used consistent with the terms and conditions of the authorization, outweigh the known and potential risks of the product. […] The primary data supporting this EUA for Evusheld are from PROVENT, a randomized, double-blind, placebo-controlled clinical trial in adults greater than age 59 or with a prespecified chronic medical condition or at increased risk of SARS-CoV-2 infection for other reasons who had not received a COVID-19 vaccine and did not have a history of SARS-CoV-2 infection or test positive for SARS-CoV-2 infection at the start of the trial. […] In the primary analysis, Evusheld recipients saw a 77% reduced risk of developing COVID-19 compared to those who received a placebo, a statistically significant difference. […] The safety and effectiveness of Evusheld for use in the pre-exposure prevention of COVID-19 continue to be evaluated.

• #25 Postexposure-vaccine-prophylaxis against COVID-19 – PubMed

  https://pubmed.ncbi.nlm.nih.gov/36324272/

  During the COVID-19 pandemic, postexposure-vaccine-prophylaxis is not a practice. […] We asked whether evidence exists for reduced mortality rate following postexposure-vaccine-prophylaxis. […] Postexposure-vaccine-prophylaxis is effective against death in COVID-19 infection.

• #26 Postexposure-vaccine-prophylaxis against COVID-19 – PubMed

  https://pubmed.ncbi.nlm.nih.gov/36324272/

  During the COVID-19 pandemic, postexposure-vaccine-prophylaxis is not a practice. […] We asked whether evidence exists for reduced mortality rate following postexposure-vaccine-prophylaxis. […] Postexposure-vaccine-prophylaxis is effective against death in COVID-19 infection.

• #27

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  COVID-19 vaccines are safe. […] Safe and effective vaccines help ensure that COVID-19 does not result in severe disease and death. In 2021 alone, COVID-19 vaccines saved at least an estimated 14.4 million lives worldwide. […] The table below outlines the updated recommendations based on a persons (1) vaccination history and (2) age and health condition. Summary SAGE recommendations for COVID-19 vaccine […] Revaccination approximately 12 months after the previous dose is particularly important for those groups at higher risk of severe disease and mortality (older adults, people with chronic diseases, pregnant persons, immunocompromised persons) and health workers. […] Take whatever vaccine is made available to you, even if you have already had COVID-19. Hybrid immunity (protection from both vaccination and COVID-19 infection) enhances protection against severe disease of future COVID-19 infections and confers longer protection.

• #28 COVID-19: Symptoms, incubation, prevention, and more

  https://www.medicalnewstoday.com/articles/covid-19

  COVID-19 is a highly contagious disease that results from an infection with the virus SARS-CoV-2, a type of coronavirus. […] Even if a person has no symptoms, they can pass the infection to others. It is vital to take steps to prevent this. […] To prevent the illness, take precautions, such as washing the hands frequently, wearing a face-covering in public, and staying away from others. Isolating is especially crucial for people who feel ill. […] Vaccines are becoming available and are free for everyone in the United States. […] A person can protect themselves and prevent the spread of COVID-19 by following these guidelines: […] Get vaccinated as soon as the vaccine becomes available. […] Vaccines are starting to become available. Here, learn more about vaccines that offer protection from COVID-19. […] Meanwhile, continue with physical distancing, frequent hand washing, avoiding touching the face, and wearing a face-covering in public.

• #29

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  COVID-19 vaccines are safe. […] Safe and effective vaccines help ensure that COVID-19 does not result in severe disease and death. In 2021 alone, COVID-19 vaccines saved at least an estimated 14.4 million lives worldwide. […] The table below outlines the updated recommendations based on a persons (1) vaccination history and (2) age and health condition. Summary SAGE recommendations for COVID-19 vaccine […] Revaccination approximately 12 months after the previous dose is particularly important for those groups at higher risk of severe disease and mortality (older adults, people with chronic diseases, pregnant persons, immunocompromised persons) and health workers. […] Take whatever vaccine is made available to you, even if you have already had COVID-19. Hybrid immunity (protection from both vaccination and COVID-19 infection) enhances protection against severe disease of future COVID-19 infections and confers longer protection.

• #30

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  COVID-19 vaccines are safe. […] Safe and effective vaccines help ensure that COVID-19 does not result in severe disease and death. In 2021 alone, COVID-19 vaccines saved at least an estimated 14.4 million lives worldwide. […] The table below outlines the updated recommendations based on a persons (1) vaccination history and (2) age and health condition. Summary SAGE recommendations for COVID-19 vaccine […] Revaccination approximately 12 months after the previous dose is particularly important for those groups at higher risk of severe disease and mortality (older adults, people with chronic diseases, pregnant persons, immunocompromised persons) and health workers. […] Take whatever vaccine is made available to you, even if you have already had COVID-19. Hybrid immunity (protection from both vaccination and COVID-19 infection) enhances protection against severe disease of future COVID-19 infections and confers longer protection.

• #31 STAY PrEPARED: Understanding COVID-19 Pre-Exposure Prophylaxis

  https://www.contagionlive.com/view/stay-prepared-understanding-covid-19-pre-exposure-prophylaxis

  COVID-19 and Immunocompromised Individuals On May 5, 2023, the World Health Organization declared an end to the global health emergency phase of COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. The development of effective COVID-19 vaccines was paramount to the pandemic response, protecting against severe disease while helping to reduce new outbreaks of the virus. However, patients with compromised immune systems may be unable to receive adequate protection from the latest vaccinations and remain at risk of severe disease, owing to suboptimal antibody response and inadequate levels of SARS-CoV-2 neutralizing antibodies following vaccination. […] Monoclonal antibodies are synthetic proteins that mimic the immune systems ability to fight off pathogens such as the SARS-CoV-2 virus. AntiSARS-CoV-2 monoclonal antibodies have been utilized as prophylactic agents for COVID-19 in individuals with moderate to severe immune compromise. […] Currently, pemivibart is the only monoclonal antibody agent authorized for PrEP of COVID-19. As new SARS-CoV-2 variants continue to emerge, it is essential to evaluate pemivibart’s effectiveness against new variants.

• #32

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  COVID-19 vaccines are safe. […] Safe and effective vaccines help ensure that COVID-19 does not result in severe disease and death. In 2021 alone, COVID-19 vaccines saved at least an estimated 14.4 million lives worldwide. […] The table below outlines the updated recommendations based on a persons (1) vaccination history and (2) age and health condition. Summary SAGE recommendations for COVID-19 vaccine […] Revaccination approximately 12 months after the previous dose is particularly important for those groups at higher risk of severe disease and mortality (older adults, people with chronic diseases, pregnant persons, immunocompromised persons) and health workers. […] Take whatever vaccine is made available to you, even if you have already had COVID-19. Hybrid immunity (protection from both vaccination and COVID-19 infection) enhances protection against severe disease of future COVID-19 infections and confers longer protection.

• #33

  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines

  Hybrid immunity the immunity one receives from both vaccination and prior COVID-19 infection enhances protection against the severe outcomes of future COVID-19 infections and offers longer protection than infection alone. […] Yes, WHO recommends a single dose of the COVID-19 vaccine during each pregnancy. Pregnant persons are at a higher risk from COVID-19, which can affect both them and the baby. […] Vaccination during pregnancy is safe. It also benefits the baby, as it allows the antibodies created to be passed from mother to child. These antibodies can also help protect the baby for the first few months of life. […] Yes, you should get vaccinated if you are planning to get pregnant. […] There is no evidence that suggests the COVID-19 vaccines interfere with fertility. There is currently no biological evidence that antibodies from COVID-19 vaccination or vaccine ingredients could cause any problems with reproductive organs. […] If you are breastfeeding, you should get vaccinated against COVID-19 with the available vaccine according to your national recommendations.

• #34

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  COVID-19 vaccines are safe. […] Safe and effective vaccines help ensure that COVID-19 does not result in severe disease and death. In 2021 alone, COVID-19 vaccines saved at least an estimated 14.4 million lives worldwide. […] The table below outlines the updated recommendations based on a persons (1) vaccination history and (2) age and health condition. Summary SAGE recommendations for COVID-19 vaccine […] Revaccination approximately 12 months after the previous dose is particularly important for those groups at higher risk of severe disease and mortality (older adults, people with chronic diseases, pregnant persons, immunocompromised persons) and health workers. […] Take whatever vaccine is made available to you, even if you have already had COVID-19. Hybrid immunity (protection from both vaccination and COVID-19 infection) enhances protection against severe disease of future COVID-19 infections and confers longer protection.

• #35 National Organizations in Epidemiology and Infection Prevention Say COVID-19 Vaccines Should be Required for Healthcare Personnel – SHEA

  https://shea-online.org/national-organizations-in-epidemiology-and-infection-prevention-say-covid-19-vaccines-should-be-required-for-healthcare-personnel/

  Hospitals and other healthcare facilities should require employees to be vaccinated against COVID-19, according to a consensus statement by the Society for Healthcare Epidemiology of America (SHEA) and six other leading organizations representing medical professionals working in infectious diseases, infection prevention, pharmacy, pediatrics, and long-term care. […] „The COVID-19 vaccines in use in the United States have been shown to be safe and effective,” said David J. Weber, a member of the SHEA Board of Trustees and lead author of the statement. […] The COVID-19 vaccines authorized for use in the United States have been found safe and effective in preventing infection and reducing transmission. […] „Vaccinating the healthcare workforce reduces the risk of transmission by protecting patients, healthcare personnel, and communities, and maintains trust in healthcare providers and healthcare institutions,” Weber said.

• #36 COVID-19: Symptoms, incubation, prevention, and more

  https://www.medicalnewstoday.com/articles/covid-19

  COVID-19 is a highly contagious disease that results from an infection with the virus SARS-CoV-2, a type of coronavirus. […] Even if a person has no symptoms, they can pass the infection to others. It is vital to take steps to prevent this. […] To prevent the illness, take precautions, such as washing the hands frequently, wearing a face-covering in public, and staying away from others. Isolating is especially crucial for people who feel ill. […] Vaccines are becoming available and are free for everyone in the United States. […] A person can protect themselves and prevent the spread of COVID-19 by following these guidelines: […] Get vaccinated as soon as the vaccine becomes available. […] Vaccines are starting to become available. Here, learn more about vaccines that offer protection from COVID-19. […] Meanwhile, continue with physical distancing, frequent hand washing, avoiding touching the face, and wearing a face-covering in public.

• #37 COVID-19 Vaccine Providers – MN Dept. of Health

  https://www.health.state.mn.us/diseases/coronavirus/vaccine/provider.html

  CDC recommends that people ages 6 months and older receive at least one 2024-2025 COVID-19 vaccine. […] For people who are NOT moderately or severely immunocompromised: At the time of initial vaccination, depending on vaccine product, children ages 6 months to 4 years are recommended to receive two or three mRNA vaccine doses. […] People ages 5 years and older are recommended to receive one dose of an updated 2024-2025 COVID-19 vaccine. […] People ages 12 years and older have the option of receiving either the updated (2024-2025 formula) mRNA (Moderna, Pfizer-BioNTech) or updated (2024-2025 formula) Novavax vaccine. […] People 65 years of age and older, are recommended to receive two doses of any 20242025 COVID-19 vaccine 6 months apart (minimum interval 2 months). […] For people who are moderately or severely immunocompromised: People ages 6 months and older, who are immunocompromised should have three doses with at least one of the doses being the new vaccine, may also receive additional doses based on their clinical situation and should talk to their health care provider.

• #38 COVID-19 Vaccines and Pregnancy: Conversation Guide for Clinicians | ACOG

  https://www.acog.org/covid-19/covid-19-vaccines-and-pregnancy-conversation-guide-for-clinicians

  The American College of Obstetricians and Gynecologists (ACOG) strongly recommends that pregnant individuals be vaccinated against COVID-19. […] Vaccination may occur in any trimester, and emphasis should be on vaccine receipt as soon as possible to maximize maternal and fetal health. […] COVID-19 vaccines may be administered simultaneously with other vaccines, including within 14 days of receipt of another vaccine. This includes vaccines routinely administered during pregnancy, such as the influenza and Tdap vaccines. […] None of the COVID-19 vaccines available for use under emergency use authorization or U.S. Food and Drug Administration (FDA) license causes infertility or spontaneous abortion. […] There is no evidence of adverse maternal or fetal effects from vaccinating pregnant individuals with the COVID-19 vaccine, and a growing body of data demonstrates the safety of such use.

• #39

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  If you are pregnant, want to get pregnant in the future or are currently breastfeeding, getting vaccinated is important to protect you and your family. […] It is safe and effective to receive different COVID-19 vaccines and to co-administer other vaccines during the same visit; for example, with other vaccines recommended during pregnancy such as the seasonal influenza vaccine. […] Some people will experience mild side effects after being vaccinated against COVID-19. Common side effects of COVID-19 vaccines include fever, head or body aches and a sore arm. […] Vaccination should not be delayed in anticipation of newer versions of the COVID-19 vaccine. […] It takes a couple of weeks after each dose of the COVID-19 vaccine for your body to develop maximum levels of immunity you are not protected right away. […] It is still possible to get COVID-19 and spread it to others after being vaccinated, so continue to do everything you can to keep yourself and others healthy.

• #40 COVID-19 Vaccines Not Linked to Miscarriage < Yale School of Medicine

  https://medicine.yale.edu/news-article/covid-19-vaccines-not-linked-to-miscarriage/

  There is no association between the COVID-19 vaccine and miscarriage, a new Obstetrics and Gynecology study confirms. […] The CDC recommendation was to not withhold the vaccine from pregnant women because it could provide lifesaving benefits to both mom and fetus, says Sheth. […] These studies have confirmed that the vaccine is safe for pregnant women. […] There was no association between being vaccinated and having a miscarriage, the researchers found. Furthermore, the number of vaccine doses, type of vaccine (Moderna, Pfizer, etc.), and the timing of the vaccination were not linked to miscarriage. […] This is a rigorously conducted study that continues to show that the COVID-19 vaccines are safe during pregnancy, says Sheth. For women who are early in pregnancy or those who are thinking about getting pregnant, given the risks of COVID-19 disease, they should feel encouraged to go ahead and get vaccinated if they are not already.

• #41 COVID-19 Vaccines and Pregnancy: Conversation Guide for Clinicians | ACOG

  https://www.acog.org/covid-19/covid-19-vaccines-and-pregnancy-conversation-guide-for-clinicians

  The American College of Obstetricians and Gynecologists (ACOG) strongly recommends that pregnant individuals be vaccinated against COVID-19. […] Vaccination may occur in any trimester, and emphasis should be on vaccine receipt as soon as possible to maximize maternal and fetal health. […] COVID-19 vaccines may be administered simultaneously with other vaccines, including within 14 days of receipt of another vaccine. This includes vaccines routinely administered during pregnancy, such as the influenza and Tdap vaccines. […] None of the COVID-19 vaccines available for use under emergency use authorization or U.S. Food and Drug Administration (FDA) license causes infertility or spontaneous abortion. […] There is no evidence of adverse maternal or fetal effects from vaccinating pregnant individuals with the COVID-19 vaccine, and a growing body of data demonstrates the safety of such use.

• #42 COVID-19 Vaccines and Pregnancy: Conversation Guide for Clinicians | ACOG

  https://www.acog.org/covid-19/covid-19-vaccines-and-pregnancy-conversation-guide-for-clinicians

  The effectiveness of COVID-19 vaccines is similar in pregnant and non-pregnant individuals of similar age for prevention of COVID-19 infection and hospitalizations. […] COVID-19 vaccines decrease the risk of severe COVID-19 disease. […] The majority of hospitalized patients are individuals who did not receive a COVID-19 vaccine. […] For patients who do not receive a COVID-19 vaccine, the discussion should be documented in the patients medical record. During subsequent office visits, obstetriciangynecologists should address ongoing questions and concerns and offer vaccination again.

• #43 Health: Infectious Disease Epidemiology & Prevention Division: COVID-19

  https://www.in.gov/health/idepd/respiratory-disease/coronavirus/

  COVID-19 vaccination is recommended if you are pregnant, breastfeeding a baby, trying to get pregnant now, or might become pregnant in the future. […] COVID-19 vaccination during pregnancy helps: Prevent severe illness and death in women who are pregnant. Protect babies younger than 6 months old from hospitalization. […] Getting children and teens vaccinated against COVID-19 can help keep them from getting seriously ill if they do get COVID-19, including protecting them from short- and long-term complications and hospitalization. […] COVID-19 vaccines help prevent disease, hospitalization, and death. Unvaccinated people are more likely to get COVID-19 and much more likely to be hospitalized and to die from COVID-19, compared to people who are up to date with their COVID-19 vaccinations.

• #44

  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines

  Hybrid immunity the immunity one receives from both vaccination and prior COVID-19 infection enhances protection against the severe outcomes of future COVID-19 infections and offers longer protection than infection alone. […] Yes, WHO recommends a single dose of the COVID-19 vaccine during each pregnancy. Pregnant persons are at a higher risk from COVID-19, which can affect both them and the baby. […] Vaccination during pregnancy is safe. It also benefits the baby, as it allows the antibodies created to be passed from mother to child. These antibodies can also help protect the baby for the first few months of life. […] Yes, you should get vaccinated if you are planning to get pregnant. […] There is no evidence that suggests the COVID-19 vaccines interfere with fertility. There is currently no biological evidence that antibodies from COVID-19 vaccination or vaccine ingredients could cause any problems with reproductive organs. […] If you are breastfeeding, you should get vaccinated against COVID-19 with the available vaccine according to your national recommendations.

• #45 COVID-19 Vaccines and Pregnancy: Conversation Guide for Clinicians | ACOG

  https://www.acog.org/covid-19/covid-19-vaccines-and-pregnancy-conversation-guide-for-clinicians

  The American College of Obstetricians and Gynecologists (ACOG) strongly recommends that pregnant individuals be vaccinated against COVID-19. […] Vaccination may occur in any trimester, and emphasis should be on vaccine receipt as soon as possible to maximize maternal and fetal health. […] COVID-19 vaccines may be administered simultaneously with other vaccines, including within 14 days of receipt of another vaccine. This includes vaccines routinely administered during pregnancy, such as the influenza and Tdap vaccines. […] None of the COVID-19 vaccines available for use under emergency use authorization or U.S. Food and Drug Administration (FDA) license causes infertility or spontaneous abortion. […] There is no evidence of adverse maternal or fetal effects from vaccinating pregnant individuals with the COVID-19 vaccine, and a growing body of data demonstrates the safety of such use.

• #46

  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines

  Hybrid immunity the immunity one receives from both vaccination and prior COVID-19 infection enhances protection against the severe outcomes of future COVID-19 infections and offers longer protection than infection alone. […] Yes, WHO recommends a single dose of the COVID-19 vaccine during each pregnancy. Pregnant persons are at a higher risk from COVID-19, which can affect both them and the baby. […] Vaccination during pregnancy is safe. It also benefits the baby, as it allows the antibodies created to be passed from mother to child. These antibodies can also help protect the baby for the first few months of life. […] Yes, you should get vaccinated if you are planning to get pregnant. […] There is no evidence that suggests the COVID-19 vaccines interfere with fertility. There is currently no biological evidence that antibodies from COVID-19 vaccination or vaccine ingredients could cause any problems with reproductive organs. […] If you are breastfeeding, you should get vaccinated against COVID-19 with the available vaccine according to your national recommendations.

• #47 Comparing the COVID-19 Vaccines: How Are They Different? > News > Yale Medicine

  https://www.yalemedicine.org/news/covid-19-vaccine-comparison

  COVID-19 is now in its fifth year, and the subvariants of the Omicron strain continue to drive infections in the United States. The good news is that vaccines, which have been updated each year since 2022, are still expected to be effective at preventing severe disease, hospitalization, and death from COVID. […] In the U.S., infants, children, and adults ages 6 months and older are eligible to be vaccinated, according to the Centers for Disease Control and Prevention (CDC). […] The 2024-2025 updated vaccines were approved based on preclinical studies of their efficacy against circulating strains. People may still become infected even though they have been vaccinated, but the goal of the vaccines now is to prevent severe disease, hospitalization and death. […] Research has suggested that people who are infected after vaccination also are less likely to report Long COVID (defined as signs, symptoms, and conditions that continue or develop after acute COVID infection), compared to those who were not vaccinated.

• #48 COVID-19- Vaccines and Prevention

  https://www.nationwidechildrens.org/family-resources-education/family-resources-library/covid-19-vaccines-and-prevention

  You can protect yourself, your household, and your community from severe illness from COVID-19. The best prevention is to get vaccinated. COVID-19 vaccines are available for people 6 months of age and older, including pregnant and breastfeeding people. […] Vaccines help prevent COVID-19. They also reduce the severity of illness if you do get the virus. […] CDC recommends the most current COVID-19 vaccines to protect against serious illness from COVID-19. […] Wear a mask if advised. Masks can help protect you and others from COVID-19. […] The risk of getting COVID-19 is lower after exposure if you are fully vaccinated. Vaccines also reduce the risk of getting severe disease if you get infected. […] It’s especially important to keep up on recommended vaccines for other illnesses. This is true if you’re at higher risk for severe illness from COVID-19, the flu, or pneumonia. […] COVID-19 vaccines can be given at the same time as other vaccines.

• #49 RFK Jr. Misleads About Safety of COVID-19 Vaccine in Children – FactCheck.org

  https://www.factcheck.org/2025/05/rfk-jr-misleads-about-safety-of-covid-19-vaccine-in-children/

  In terms of the vaccine itself having profound risk, the risks of adverse events from vaccination for children are characterized in numerous studies, and has not been shown to be greater than the risk of COVID-19 infection in children, he told us in an email. […] A study published in January in the Annals of Internal Medicine, based on more than 144,000 children and co-authored by Morris, suggests that the Pfizer/BioNTech COVID-19 vaccine was effective in preventing moderate and severe illness and ICU admissions during the delta and omicron periods. […] According to provisional CDC data presented in the last ACIP meeting, COVID-19 was an underlying cause of death for 152 children under 18 years of age between September 2023 and August 2024. […] Moser, from the Childrens Hospital of Philadelphias Vaccine Education Center, supports a risk-based recommendation that considers age and health condition for those who are previously vaccinated and a universal recommendation for young children and others who have never been vaccinated.

• #50 Health: Infectious Disease Epidemiology & Prevention Division: COVID-19

  https://www.in.gov/health/idepd/respiratory-disease/coronavirus/

  COVID-19 vaccination is recommended if you are pregnant, breastfeeding a baby, trying to get pregnant now, or might become pregnant in the future. […] COVID-19 vaccination during pregnancy helps: Prevent severe illness and death in women who are pregnant. Protect babies younger than 6 months old from hospitalization. […] Getting children and teens vaccinated against COVID-19 can help keep them from getting seriously ill if they do get COVID-19, including protecting them from short- and long-term complications and hospitalization. […] COVID-19 vaccines help prevent disease, hospitalization, and death. Unvaccinated people are more likely to get COVID-19 and much more likely to be hospitalized and to die from COVID-19, compared to people who are up to date with their COVID-19 vaccinations.

• #51 COVID-19: Symptoms, incubation, prevention, and more

  https://www.medicalnewstoday.com/articles/covid-19

  COVID-19 is a highly contagious disease that results from an infection with the virus SARS-CoV-2, a type of coronavirus. […] Even if a person has no symptoms, they can pass the infection to others. It is vital to take steps to prevent this. […] To prevent the illness, take precautions, such as washing the hands frequently, wearing a face-covering in public, and staying away from others. Isolating is especially crucial for people who feel ill. […] Vaccines are becoming available and are free for everyone in the United States. […] A person can protect themselves and prevent the spread of COVID-19 by following these guidelines: […] Get vaccinated as soon as the vaccine becomes available. […] Vaccines are starting to become available. Here, learn more about vaccines that offer protection from COVID-19. […] Meanwhile, continue with physical distancing, frequent hand washing, avoiding touching the face, and wearing a face-covering in public.

• #52 COVID-19- Vaccines and Prevention

  https://www.nationwidechildrens.org/family-resources-education/family-resources-library/covid-19-vaccines-and-prevention

  You can protect yourself, your household, and your community from severe illness from COVID-19. The best prevention is to get vaccinated. COVID-19 vaccines are available for people 6 months of age and older, including pregnant and breastfeeding people. […] Vaccines help prevent COVID-19. They also reduce the severity of illness if you do get the virus. […] CDC recommends the most current COVID-19 vaccines to protect against serious illness from COVID-19. […] Wear a mask if advised. Masks can help protect you and others from COVID-19. […] The risk of getting COVID-19 is lower after exposure if you are fully vaccinated. Vaccines also reduce the risk of getting severe disease if you get infected. […] It’s especially important to keep up on recommended vaccines for other illnesses. This is true if you’re at higher risk for severe illness from COVID-19, the flu, or pneumonia. […] COVID-19 vaccines can be given at the same time as other vaccines.

• #53 COVID-19 Vaccine Providers – MN Dept. of Health

  https://www.health.state.mn.us/diseases/coronavirus/vaccine/provider.html

  CDC recommends that people ages 6 months and older receive at least one 2024-2025 COVID-19 vaccine. […] For people who are NOT moderately or severely immunocompromised: At the time of initial vaccination, depending on vaccine product, children ages 6 months to 4 years are recommended to receive two or three mRNA vaccine doses. […] People ages 5 years and older are recommended to receive one dose of an updated 2024-2025 COVID-19 vaccine. […] People ages 12 years and older have the option of receiving either the updated (2024-2025 formula) mRNA (Moderna, Pfizer-BioNTech) or updated (2024-2025 formula) Novavax vaccine. […] People 65 years of age and older, are recommended to receive two doses of any 20242025 COVID-19 vaccine 6 months apart (minimum interval 2 months). […] For people who are moderately or severely immunocompromised: People ages 6 months and older, who are immunocompromised should have three doses with at least one of the doses being the new vaccine, may also receive additional doses based on their clinical situation and should talk to their health care provider.

• #54 COVID-19 Vaccine Providers – MN Dept. of Health

  https://www.health.state.mn.us/diseases/coronavirus/vaccine/provider.html

  CDC recommends that people ages 6 months and older receive at least one 2024-2025 COVID-19 vaccine. […] For people who are NOT moderately or severely immunocompromised: At the time of initial vaccination, depending on vaccine product, children ages 6 months to 4 years are recommended to receive two or three mRNA vaccine doses. […] People ages 5 years and older are recommended to receive one dose of an updated 2024-2025 COVID-19 vaccine. […] People ages 12 years and older have the option of receiving either the updated (2024-2025 formula) mRNA (Moderna, Pfizer-BioNTech) or updated (2024-2025 formula) Novavax vaccine. […] People 65 years of age and older, are recommended to receive two doses of any 20242025 COVID-19 vaccine 6 months apart (minimum interval 2 months). […] For people who are moderately or severely immunocompromised: People ages 6 months and older, who are immunocompromised should have three doses with at least one of the doses being the new vaccine, may also receive additional doses based on their clinical situation and should talk to their health care provider.

• #55 COVID-19 Vaccine Providers – MN Dept. of Health

  https://www.health.state.mn.us/diseases/coronavirus/vaccine/provider.html

  CDC recommends that people ages 6 months and older receive at least one 2024-2025 COVID-19 vaccine. […] For people who are NOT moderately or severely immunocompromised: At the time of initial vaccination, depending on vaccine product, children ages 6 months to 4 years are recommended to receive two or three mRNA vaccine doses. […] People ages 5 years and older are recommended to receive one dose of an updated 2024-2025 COVID-19 vaccine. […] People ages 12 years and older have the option of receiving either the updated (2024-2025 formula) mRNA (Moderna, Pfizer-BioNTech) or updated (2024-2025 formula) Novavax vaccine. […] People 65 years of age and older, are recommended to receive two doses of any 20242025 COVID-19 vaccine 6 months apart (minimum interval 2 months). […] For people who are moderately or severely immunocompromised: People ages 6 months and older, who are immunocompromised should have three doses with at least one of the doses being the new vaccine, may also receive additional doses based on their clinical situation and should talk to their health care provider.

• #56 COVID-19 Vaccine Providers – MN Dept. of Health

  https://www.health.state.mn.us/diseases/coronavirus/vaccine/provider.html

  CDC recommends that people ages 6 months and older receive at least one 2024-2025 COVID-19 vaccine. […] For people who are NOT moderately or severely immunocompromised: At the time of initial vaccination, depending on vaccine product, children ages 6 months to 4 years are recommended to receive two or three mRNA vaccine doses. […] People ages 5 years and older are recommended to receive one dose of an updated 2024-2025 COVID-19 vaccine. […] People ages 12 years and older have the option of receiving either the updated (2024-2025 formula) mRNA (Moderna, Pfizer-BioNTech) or updated (2024-2025 formula) Novavax vaccine. […] People 65 years of age and older, are recommended to receive two doses of any 20242025 COVID-19 vaccine 6 months apart (minimum interval 2 months). […] For people who are moderately or severely immunocompromised: People ages 6 months and older, who are immunocompromised should have three doses with at least one of the doses being the new vaccine, may also receive additional doses based on their clinical situation and should talk to their health care provider.

• #57 COVID-19: Vaccine Safety and Effectiveness | Wisconsin Department of Health Services

  https://www.dhs.wisconsin.gov/covid-19/vaccine-safety.htm

  COVID-19 vaccines are safe and effective. Hundreds of millions of people have received COVID-19 vaccines under the most intense safety monitoring in U.S. history. […] It is recommended that everyone 6 months and older get vaccinated as soon as possible. […] Everyone 6 months and older in the United States is recommended to get a 20242025 updated COVID-19 vaccine for the best protection against serious illness from COVID-19. […] All COVID-19 vaccines are effective in preventing serious outcomes of COVID-19, including severe disease, hospitalization, and death. […] Clinical trials and vaccine effectiveness studies show that being up to date with COVID-19 vaccines provides strong protection against severe disease, hospitalization, and death in all age groups. All eligible people should remain up to date on their COVID-19 vaccines for the best protection.

• #58 COVID-19: Vaccine Safety and Effectiveness | Wisconsin Department of Health Services

  https://www.dhs.wisconsin.gov/covid-19/vaccine-safety.htm

  COVID-19 vaccines were, and continue to be, tested in large clinical trials, made up of far more participants than is usually required, to make sure they met well-established safety standards. […] The following systems continue to track common side effects and rare adverse, sometimes serious, reactions in people who receive any vaccine, including COVID-19 vaccines.

• #59

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  If you are pregnant, want to get pregnant in the future or are currently breastfeeding, getting vaccinated is important to protect you and your family. […] It is safe and effective to receive different COVID-19 vaccines and to co-administer other vaccines during the same visit; for example, with other vaccines recommended during pregnancy such as the seasonal influenza vaccine. […] Some people will experience mild side effects after being vaccinated against COVID-19. Common side effects of COVID-19 vaccines include fever, head or body aches and a sore arm. […] Vaccination should not be delayed in anticipation of newer versions of the COVID-19 vaccine. […] It takes a couple of weeks after each dose of the COVID-19 vaccine for your body to develop maximum levels of immunity you are not protected right away. […] It is still possible to get COVID-19 and spread it to others after being vaccinated, so continue to do everything you can to keep yourself and others healthy.

• #60

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  If you are pregnant, want to get pregnant in the future or are currently breastfeeding, getting vaccinated is important to protect you and your family. […] It is safe and effective to receive different COVID-19 vaccines and to co-administer other vaccines during the same visit; for example, with other vaccines recommended during pregnancy such as the seasonal influenza vaccine. […] Some people will experience mild side effects after being vaccinated against COVID-19. Common side effects of COVID-19 vaccines include fever, head or body aches and a sore arm. […] Vaccination should not be delayed in anticipation of newer versions of the COVID-19 vaccine. […] It takes a couple of weeks after each dose of the COVID-19 vaccine for your body to develop maximum levels of immunity you are not protected right away. […] It is still possible to get COVID-19 and spread it to others after being vaccinated, so continue to do everything you can to keep yourself and others healthy.

• #61 COVID-19 Vaccine

  https://www.sandiegocounty.gov/content/sdc/hhsa/programs/phs/community_epidemiology/dc/2019-nCoV/vaccines.html

  Currently, there are 2 types of COVID-19 vaccines for use in the United States: mRNA (Pfizer-BioNTech or Moderna) […] Protein subunit vaccines (Novavax). […] Side effects are a sign that the vaccine is working. […] All steps were taken to ensure COVID-19 vaccine safety and effectiveness, including: Clinical Trials All vaccines in the United States must go through three phases of clinical trials to ensure they are safe and effective. […] Before vaccines are available to people, the U.S. Food and Drug Administration (FDA) reviews data from clinical trials. […] COVID-19 vaccines continue to be monitored for safety and effectiveness. […] Hundreds of millions of people in the United States have safely received COVID-19 vaccines.

• #62

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  If you are pregnant, want to get pregnant in the future or are currently breastfeeding, getting vaccinated is important to protect you and your family. […] It is safe and effective to receive different COVID-19 vaccines and to co-administer other vaccines during the same visit; for example, with other vaccines recommended during pregnancy such as the seasonal influenza vaccine. […] Some people will experience mild side effects after being vaccinated against COVID-19. Common side effects of COVID-19 vaccines include fever, head or body aches and a sore arm. […] Vaccination should not be delayed in anticipation of newer versions of the COVID-19 vaccine. […] It takes a couple of weeks after each dose of the COVID-19 vaccine for your body to develop maximum levels of immunity you are not protected right away. […] It is still possible to get COVID-19 and spread it to others after being vaccinated, so continue to do everything you can to keep yourself and others healthy.

• #63 COVID-19: Vaccine Safety and Effectiveness | Wisconsin Department of Health Services

  https://www.dhs.wisconsin.gov/covid-19/vaccine-safety.htm

  COVID-19 vaccines were, and continue to be, tested in large clinical trials, made up of far more participants than is usually required, to make sure they met well-established safety standards. […] The following systems continue to track common side effects and rare adverse, sometimes serious, reactions in people who receive any vaccine, including COVID-19 vaccines.

• #64 Health Alert on mRNA COVID-19 Vaccine Safety | Florida Department of Health

  https://www.floridahealth.gov/newsroom/2023/02/20230215-updated-health-alert.pr.html

  The State Surgeon General is notifying the health care sector and public of a substantial increase in Vaccine Adverse Event Reporting System (VAERS) reports from Florida after the COVID-19 vaccine rollout. […] In Florida alone, there was a 1,700% increase in VAERS reports after the release of the COVID-19 vaccine, compared to an increase of 400% in overall vaccine administration for the same time period. […] The reporting of life-threatening conditions increased over 4,400%. This is a novel increase and was not seen during the 2009 H1N1 vaccination campaign. There is a need for additional unbiased research to better understand the COVID-19 vaccines’ short- and long-term effects. […] The findings in Florida are consistent with various studies that continue to uncover such risks. […] According to a study, Fraiman J et al, Vaccine. 2022, mRNA COVID-19 vaccines were associated with an excess risk of serious adverse events, including coagulation disorders, acute cardiac injuries, Bells palsy, and encephalitis.

• #65 Health Alert on mRNA COVID-19 Vaccine Safety | Florida Department of Health

  https://www.floridahealth.gov/newsroom/2023/02/20230215-updated-health-alert.pr.html

  A second study, Sun CLF et al, Sci Rep. 2022, found increased acute cardiac arrests and other acute cardiac events following mRNA COVID-19 vaccination. […] Additionally, Dag Berild J et al, JAMA Netw Open. 2022, assessed the risk of thromboembolic and thrombocytopenic events related to COVID-19 vaccines and found preliminary evidence of increased risk of both coronary disease and cardiovascular disease. […] While the CDC has identified safety signals for stroke among individuals 65 and older following the bivalent booster administration, there is a need for additional assessments and research regarding safety of all mRNA COVID-19 vaccines. […] To support transparency, the State of Florida reminds health care providers to accurately communicate the risks and benefits of all clinical interventions to their patients, including those associated with the COVID-19 vaccine as additional risks continue to be identified and disclosed to the public. […] The State of Florida remains dedicated to protecting communities from the risks of COVID-19 and other public health concerns, specifically by promoting the importance of treatment and promoting prevention through healthy habits.

• #66 COVID-19: Vaccine Safety and Effectiveness | Wisconsin Department of Health Services

  https://www.dhs.wisconsin.gov/covid-19/vaccine-safety.htm

  COVID-19 vaccines were, and continue to be, tested in large clinical trials, made up of far more participants than is usually required, to make sure they met well-established safety standards. […] The following systems continue to track common side effects and rare adverse, sometimes serious, reactions in people who receive any vaccine, including COVID-19 vaccines.

• #67 Comparing the COVID-19 Vaccines: How Are They Different? > News > Yale Medicine

  https://www.yalemedicine.org/news/covid-19-vaccine-comparison

  COVID-19 is now in its fifth year, and the subvariants of the Omicron strain continue to drive infections in the United States. The good news is that vaccines, which have been updated each year since 2022, are still expected to be effective at preventing severe disease, hospitalization, and death from COVID. […] In the U.S., infants, children, and adults ages 6 months and older are eligible to be vaccinated, according to the Centers for Disease Control and Prevention (CDC). […] The 2024-2025 updated vaccines were approved based on preclinical studies of their efficacy against circulating strains. People may still become infected even though they have been vaccinated, but the goal of the vaccines now is to prevent severe disease, hospitalization and death. […] Research has suggested that people who are infected after vaccination also are less likely to report Long COVID (defined as signs, symptoms, and conditions that continue or develop after acute COVID infection), compared to those who were not vaccinated.

• #68 History of COVID-19: Outbreaks and vaccine timeline

  https://www.mayoclinic.org/diseases-conditions/history-disease-outbreaks-vaccine-timeline/covid-19

  Find out more about the COVID-19 pandemic, COVID-19 tests, COVID-19 treatments, mRNA research and COVID-19 vaccines. […] Researchers also study COVID-19 symptoms, long-term effects, diagnostic tests, antibody tests, treatments and drugs. […] The FDA gives emergency use authorization to two mRNA COVID-19 vaccines, the Pfizer-BioNTech and the Moderna COVID-19 vaccines. […] Researchers at Mayo Clinic and other medical centers continue to study more vaccines that prevent COVID-19. […] The FDA gives emergency use authorization to the Janssen/Johnson Johnson COVID-19 vaccine. […] The FDA approves the Pfizer-BioNTech COVID-19 vaccine, now called Comirnaty, to prevent COVID-19 in people age 16 and older. […] The FDA approves the Moderna COVID-19 vaccine, now called Spikevax, to prevent COVID-19 in people age 18 and older. […] The FDA recommends certain strains of the COVID-19 virus be targeted in the 2024-2025 COVID-19 vaccines based off the virus strains that are spreading.

• #69 Comparing the COVID-19 Vaccines: How Are They Different? > News > Yale Medicine

  https://www.yalemedicine.org/news/covid-19-vaccine-comparison

  The FDA granted the Moderna vaccine (brand name: Spikevax) full approval for people 18 and older in January 2022, upgrading the vaccines EUA, which was granted in December 2020. […] The Novavax vaccine (brand names: Nuvaxovid and Covovax) was the fourth COVID vaccine to be administered in the U.S. […] The FDA authorized an updated COVID vaccine from Novavax at the end of August 2024 for everyone ages 12 and older. […] Understanding how effective the latest updated vaccines are in the real world beyond the clinical trials can be difficult, since companies manufacture updated vaccines based on preclinical information and educated predictions of which variants will be circulating when the shots become available. […] The 2024-2025 updated COVID vaccines are available at participating pharmacies and provider offices.

• #70 History of COVID-19: Outbreaks and vaccine timeline

  https://www.mayoclinic.org/diseases-conditions/history-disease-outbreaks-vaccine-timeline/covid-19

  Find out more about the COVID-19 pandemic, COVID-19 tests, COVID-19 treatments, mRNA research and COVID-19 vaccines. […] Researchers also study COVID-19 symptoms, long-term effects, diagnostic tests, antibody tests, treatments and drugs. […] The FDA gives emergency use authorization to two mRNA COVID-19 vaccines, the Pfizer-BioNTech and the Moderna COVID-19 vaccines. […] Researchers at Mayo Clinic and other medical centers continue to study more vaccines that prevent COVID-19. […] The FDA gives emergency use authorization to the Janssen/Johnson Johnson COVID-19 vaccine. […] The FDA approves the Pfizer-BioNTech COVID-19 vaccine, now called Comirnaty, to prevent COVID-19 in people age 16 and older. […] The FDA approves the Moderna COVID-19 vaccine, now called Spikevax, to prevent COVID-19 in people age 18 and older. […] The FDA recommends certain strains of the COVID-19 virus be targeted in the 2024-2025 COVID-19 vaccines based off the virus strains that are spreading.

• #71 Influenza COVID-19 Combination Vaccine Induces Higher Immune Response Than Standalone Immunizations

  https://www.contagionlive.com/view/influenza-covid-19-combination-vaccine-provides-induces-higher-immune-response-than-standalone-immunizations

  The mRNA platform used to develop mRNA-1083 has numerous advantages, including avoidance of egg adaptation-related changes as well as the breadth of immunity and T-cell responses for the influenza component (mRNA-1010), they wrote. Additionally, the rapid production and flexibility for updates to vaccine composition can ensure close matching to circulating influenza and SARS-CoV-2 virus strains. Further, the platform can quickly adapt to allow for timely and effective public health responses, especially in the face of emerging variants and strains.

• #72 Comparing the COVID-19 Vaccines: How Are They Different? > News > Yale Medicine

  https://www.yalemedicine.org/news/covid-19-vaccine-comparison

  The FDA granted the Moderna vaccine (brand name: Spikevax) full approval for people 18 and older in January 2022, upgrading the vaccines EUA, which was granted in December 2020. […] The Novavax vaccine (brand names: Nuvaxovid and Covovax) was the fourth COVID vaccine to be administered in the U.S. […] The FDA authorized an updated COVID vaccine from Novavax at the end of August 2024 for everyone ages 12 and older. […] Understanding how effective the latest updated vaccines are in the real world beyond the clinical trials can be difficult, since companies manufacture updated vaccines based on preclinical information and educated predictions of which variants will be circulating when the shots become available. […] The 2024-2025 updated COVID vaccines are available at participating pharmacies and provider offices.

• #73 Comparing the COVID-19 Vaccines: How Are They Different? > News > Yale Medicine

  https://www.yalemedicine.org/news/covid-19-vaccine-comparison

  COVID-19 is now in its fifth year, and the subvariants of the Omicron strain continue to drive infections in the United States. The good news is that vaccines, which have been updated each year since 2022, are still expected to be effective at preventing severe disease, hospitalization, and death from COVID. […] In the U.S., infants, children, and adults ages 6 months and older are eligible to be vaccinated, according to the Centers for Disease Control and Prevention (CDC). […] The 2024-2025 updated vaccines were approved based on preclinical studies of their efficacy against circulating strains. People may still become infected even though they have been vaccinated, but the goal of the vaccines now is to prevent severe disease, hospitalization and death. […] Research has suggested that people who are infected after vaccination also are less likely to report Long COVID (defined as signs, symptoms, and conditions that continue or develop after acute COVID infection), compared to those who were not vaccinated.

• #74

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  If you are pregnant, want to get pregnant in the future or are currently breastfeeding, getting vaccinated is important to protect you and your family. […] It is safe and effective to receive different COVID-19 vaccines and to co-administer other vaccines during the same visit; for example, with other vaccines recommended during pregnancy such as the seasonal influenza vaccine. […] Some people will experience mild side effects after being vaccinated against COVID-19. Common side effects of COVID-19 vaccines include fever, head or body aches and a sore arm. […] Vaccination should not be delayed in anticipation of newer versions of the COVID-19 vaccine. […] It takes a couple of weeks after each dose of the COVID-19 vaccine for your body to develop maximum levels of immunity you are not protected right away. […] It is still possible to get COVID-19 and spread it to others after being vaccinated, so continue to do everything you can to keep yourself and others healthy.

• #75 Influenza COVID-19 Combination Vaccine Induces Higher Immune Response Than Standalone Immunizations

  https://www.contagionlive.com/view/influenza-covid-19-combination-vaccine-provides-induces-higher-immune-response-than-standalone-immunizations

  Modernas late-stage investigational influenza COVID-19 vaccine was shown to be noninferior in comparison to other vaccines and elicited better immune responses. […] Moderna’s combination vaccine induced a higher immune response than standalone influenza and COVID-19 vaccines, showing noninferiority and better performance against all influenza strains and SARS-CoV-2 in adults aged 50+. […] The vaccine demonstrated an acceptable safety and tolerability profile, with data from over 8,000 participants in a Phase 3 US-based study. […] Noninferiority of mRNA-1083 vs SD-IIV4 plus mRNA-1273 and HD-IIV4 plus mRNA-1273 was demonstrated against all vaccine-matched influenza and SARS-CoV-2 strains based on prespecified success criteria for GMR (97.5% CI lower bound 0.667) and seroconversion/seroresponse rate difference (97.5% CI lower bound 10%), the investigators wrote.

• #76 Influenza COVID-19 Combination Vaccine Induces Higher Immune Response Than Standalone Immunizations

  https://www.contagionlive.com/view/influenza-covid-19-combination-vaccine-provides-induces-higher-immune-response-than-standalone-immunizations

  Modernas late-stage investigational influenza COVID-19 vaccine was shown to be noninferior in comparison to other vaccines and elicited better immune responses. […] Moderna’s combination vaccine induced a higher immune response than standalone influenza and COVID-19 vaccines, showing noninferiority and better performance against all influenza strains and SARS-CoV-2 in adults aged 50+. […] The vaccine demonstrated an acceptable safety and tolerability profile, with data from over 8,000 participants in a Phase 3 US-based study. […] Noninferiority of mRNA-1083 vs SD-IIV4 plus mRNA-1273 and HD-IIV4 plus mRNA-1273 was demonstrated against all vaccine-matched influenza and SARS-CoV-2 strains based on prespecified success criteria for GMR (97.5% CI lower bound 0.667) and seroconversion/seroresponse rate difference (97.5% CI lower bound 10%), the investigators wrote.

• #77 Influenza COVID-19 Combination Vaccine Induces Higher Immune Response Than Standalone Immunizations

  https://www.contagionlive.com/view/influenza-covid-19-combination-vaccine-provides-induces-higher-immune-response-than-standalone-immunizations

  Modernas late-stage investigational influenza COVID-19 vaccine was shown to be noninferior in comparison to other vaccines and elicited better immune responses. […] Moderna’s combination vaccine induced a higher immune response than standalone influenza and COVID-19 vaccines, showing noninferiority and better performance against all influenza strains and SARS-CoV-2 in adults aged 50+. […] The vaccine demonstrated an acceptable safety and tolerability profile, with data from over 8,000 participants in a Phase 3 US-based study. […] Noninferiority of mRNA-1083 vs SD-IIV4 plus mRNA-1273 and HD-IIV4 plus mRNA-1273 was demonstrated against all vaccine-matched influenza and SARS-CoV-2 strains based on prespecified success criteria for GMR (97.5% CI lower bound 0.667) and seroconversion/seroresponse rate difference (97.5% CI lower bound 10%), the investigators wrote.

• #78 Influenza COVID-19 Combination Vaccine Induces Higher Immune Response Than Standalone Immunizations

  https://www.contagionlive.com/view/influenza-covid-19-combination-vaccine-provides-induces-higher-immune-response-than-standalone-immunizations

  The mRNA platform used to develop mRNA-1083 has numerous advantages, including avoidance of egg adaptation-related changes as well as the breadth of immunity and T-cell responses for the influenza component (mRNA-1010), they wrote. Additionally, the rapid production and flexibility for updates to vaccine composition can ensure close matching to circulating influenza and SARS-CoV-2 virus strains. Further, the platform can quickly adapt to allow for timely and effective public health responses, especially in the face of emerging variants and strains.

• #79

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  If you are pregnant, want to get pregnant in the future or are currently breastfeeding, getting vaccinated is important to protect you and your family. […] It is safe and effective to receive different COVID-19 vaccines and to co-administer other vaccines during the same visit; for example, with other vaccines recommended during pregnancy such as the seasonal influenza vaccine. […] Some people will experience mild side effects after being vaccinated against COVID-19. Common side effects of COVID-19 vaccines include fever, head or body aches and a sore arm. […] Vaccination should not be delayed in anticipation of newer versions of the COVID-19 vaccine. […] It takes a couple of weeks after each dose of the COVID-19 vaccine for your body to develop maximum levels of immunity you are not protected right away. […] It is still possible to get COVID-19 and spread it to others after being vaccinated, so continue to do everything you can to keep yourself and others healthy.

• #80 COVID-19- Vaccines and Prevention

  https://www.nationwidechildrens.org/family-resources-education/family-resources-library/covid-19-vaccines-and-prevention

  You can protect yourself, your household, and your community from severe illness from COVID-19. The best prevention is to get vaccinated. COVID-19 vaccines are available for people 6 months of age and older, including pregnant and breastfeeding people. […] Vaccines help prevent COVID-19. They also reduce the severity of illness if you do get the virus. […] CDC recommends the most current COVID-19 vaccines to protect against serious illness from COVID-19. […] Wear a mask if advised. Masks can help protect you and others from COVID-19. […] The risk of getting COVID-19 is lower after exposure if you are fully vaccinated. Vaccines also reduce the risk of getting severe disease if you get infected. […] It’s especially important to keep up on recommended vaccines for other illnesses. This is true if you’re at higher risk for severe illness from COVID-19, the flu, or pneumonia. […] COVID-19 vaccines can be given at the same time as other vaccines.

• #81 COVID-19 | Department of Health

  https://coronavirus.health.ny.gov/home

  All New Yorkers 6 months and older can now get the updated vaccine at a location near you. […] Everyone 6 months of age and older are eligible to receive the COVID-19 vaccine. COVID-19 vaccines are widely available at pharmacies, doctors offices, local health departments, clinics, and Federally Qualified Health Centers. […] The COVID-19 vaccine is safe, effective and will help protect babies, toddlers, and children 6 months of age and older. […] Follow these safety measures to protect yourself and your family.

• #82 COVID-19 vaccine | Colorado Department of Public Health and Environment

  https://cdphe.colorado.gov/covid-19/vaccine

  Getting vaccinated against COVID-19 is the safest, easiest way to lower your risk of serious illness, Long COVID, hospitalization, and death. Everyone aged 6 months and older is recommended to stay up to date with COVID-19 vaccines. […] Everyone aged 6 months and older should get a 2024-2025 COVID-19 vaccine. Most people only need one dose of the updated vaccine. Its safe to get your COVID-19 vaccine and flu vaccine at the same appointment. […] Talking with a health care provider can help you learn more about how many doses you or your child needs and when to schedule them. However, a conversation with a health care provider is not required to get vaccinated. […] If you dont have insurance, or your insurance doesnt cover COVID-19 vaccines, you can still get vaccinated at low or no cost. […] A Colorado law called Individual Access to Publicly Funded Vaccines helps make sure people can get the COVID-19 vaccine even if they dont have health insurance or cant afford to pay a fee.

• #83 Commercialization of COVID-19 Vaccines, Treatments, and Tests: Implications for Access and Coverage | KFF

  https://www.kff.org/coronavirus-covid-19/issue-brief/commercialization-of-covid-19-vaccines-treatments-and-tests-implications-for-access-and-coverage/

  Medicare covered COVID-19 vaccines, including boosters, for beneficiaries at no cost in traditional Medicare and Medicare Advantage under Medicare Part B. This is due to statutory changes that were made by the CARES Act which added coverage of FDA-approved COVID-19 vaccines to Part B. […] Medicare beneficiaries continue to have access to COVID-19 vaccines, including boosters, at no cost under Part B. […] Provisions in the American Rescue Plan Act (ARPA) and the Inflation Reduction Act (IRA) require Medicaid and CHIP programs to cover all ACIP-recommended vaccines, including COVID-19 vaccines/boosters, with no cost sharing even when the PHE ends and there is no longer any supply of federally purchased vaccines. […] Uninsured individuals could obtain COVID-19 vaccines, including boosters, for free from any provider participating in the CDC COVID-19 Vaccination Program.

• #84 Commercialization of COVID-19 Vaccines, Treatments, and Tests: Implications for Access and Coverage | KFF

  https://www.kff.org/coronavirus-covid-19/issue-brief/commercialization-of-covid-19-vaccines-treatments-and-tests-implications-for-access-and-coverage/

  Medicare covered COVID-19 vaccines, including boosters, for beneficiaries at no cost in traditional Medicare and Medicare Advantage under Medicare Part B. This is due to statutory changes that were made by the CARES Act which added coverage of FDA-approved COVID-19 vaccines to Part B. […] Medicare beneficiaries continue to have access to COVID-19 vaccines, including boosters, at no cost under Part B. […] Provisions in the American Rescue Plan Act (ARPA) and the Inflation Reduction Act (IRA) require Medicaid and CHIP programs to cover all ACIP-recommended vaccines, including COVID-19 vaccines/boosters, with no cost sharing even when the PHE ends and there is no longer any supply of federally purchased vaccines. […] Uninsured individuals could obtain COVID-19 vaccines, including boosters, for free from any provider participating in the CDC COVID-19 Vaccination Program.

• #85 Commercialization of COVID-19 Vaccines, Treatments, and Tests: Implications for Access and Coverage | KFF

  https://www.kff.org/coronavirus-covid-19/issue-brief/commercialization-of-covid-19-vaccines-treatments-and-tests-implications-for-access-and-coverage/

  To address the lack of guaranteed access to free COVID-19 vaccines, the Biden administration created the Bridge Access Program, a public-private partnership to provide vaccine access at local pharmacies, through existing public health infrastructure, and at local health centers. Financed with $1.1 billion in funds already appropriated during the COVID-19 emergency, vaccines are purchased through the CDCs Section 317 program, which provides vaccines to uninsured adults, and distributed through that network of state and local health departments and community health centers. This program will run through December 2024.

• #86 COVID-19 vaccination

  https://www.ecdc.europa.eu/en/covid-19/prevention-and-control/vaccines

  Safe and effective COVID-19 vaccines are a powerful tool for ensuring public health and controlling the pandemic. Results from observational studies carried out to date have shown that the vaccines authorised in the EU/EEA are currently highly protective against severe COVID-19, hospitalisation and death. […] Assessing the effectiveness, safety and impact of COVID-19 vaccines is the key to ensuring that they function as expected, picking up any possible safety signals and providing information if vaccination strategies need to be adapted. […] ECDC reviews scientific evidence and develops relevant technical guidance on COVID-19 vaccines that can inform national priorities and decision-making. […] The acceptance and uptake of the vaccines by the population is the key to a successful COVID-19 vaccination programme.

• #87

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  COVID-19 vaccines are safe. […] Safe and effective vaccines help ensure that COVID-19 does not result in severe disease and death. In 2021 alone, COVID-19 vaccines saved at least an estimated 14.4 million lives worldwide. […] The table below outlines the updated recommendations based on a persons (1) vaccination history and (2) age and health condition. Summary SAGE recommendations for COVID-19 vaccine […] Revaccination approximately 12 months after the previous dose is particularly important for those groups at higher risk of severe disease and mortality (older adults, people with chronic diseases, pregnant persons, immunocompromised persons) and health workers. […] Take whatever vaccine is made available to you, even if you have already had COVID-19. Hybrid immunity (protection from both vaccination and COVID-19 infection) enhances protection against severe disease of future COVID-19 infections and confers longer protection.

• #88

  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines

  All COVID-19 vaccines, listed by WHO as for emergency use or prequalified, provide protection against severe disease and death resulting from COVID-19 infection. […] For optimal protection, it is important to receive the recommended COVID-19 vaccine doses. Consult with your health care provider for specific advice. […] Revaccination is recommended 6 to 12 months after the last dose for high-risk persons including older adults, individuals with chronic and/or immunocompromised conditions and health workers with direct patient contact. Revaccination during each pregnancy is recommended. […] Vaccination is recommended for those who have never received any COVID-19 vaccine and are at high risk of severe illness such as older persons, adults with chronic diseases, individuals with immunocompromising conditions and health workers with direct patient contact. Pregnant persons should get one dose.

• #89 Coronavirus: Vaccine Information and PlanningIN.gov

  https://www.coronavirus.in.gov/vaccine/

  There are precautions you can take to prevent serious illness from COVID-19. The safe and effective vaccine is the best way to build protection. […] The U.S. Food and Drug Administration (FDA) has approved and authorized an updated Moderna, Pfizer 2024 COVID-19 vaccine. The Centers for Disease Control and Prevention (CDC) also recommends everyone 6 months and older get an updated COVID-19 vaccine to protect against the potentially serious outcomes of COVID-19 illness. […] Adults ages 65 and older can now to receive an additional updated 2024-2025 COVID-19 vaccine dose as long as four months have passed since their last dose. Adults in this age range are at greater risk for severe outcomes of COVID-19, and an additional dose of the updated COVID-19 vaccine may restore protection that has waned since a fall vaccine dose.

• #90 COVID-19 Vaccine – Schedule Your COVID-19 Vaccine Appointment at CVS

  https://www.cvs.com/immunizations/covid-19-vaccine

  No-cost COVID-19 vaccines for you and your family […] Updated COVID-19 vaccines are available. Age and other restrictions apply.* No cost with most insurance. […] The Centers for Disease Control and Prevention (CDC) recommends a second dose of the updated COVID-19 vaccine for adults 65 years or older and those who are immunocompromised. […] Getting a pediatric COVID-19 vaccine can help keep children from getting seriously sick. Consult your health care provider for more guidance and information. […] COVID-19 vaccines are safe and effective. To date, hundreds of millions of people have safely received a COVID-19 vaccine under the most intense safety monitoring in U.S. history. […] All the COVID-19 vaccines recommended by the CDC are safe. People age 65 or older should receive the recommended number of dose(s) of the updated COVID-19 vaccine (2024–2025 formula).

• #91 COVID-19: Symptoms, incubation, prevention, and more

  https://www.medicalnewstoday.com/articles/covid-19

  COVID-19 is a highly contagious disease that results from an infection with the virus SARS-CoV-2, a type of coronavirus. […] Even if a person has no symptoms, they can pass the infection to others. It is vital to take steps to prevent this. […] To prevent the illness, take precautions, such as washing the hands frequently, wearing a face-covering in public, and staying away from others. Isolating is especially crucial for people who feel ill. […] Vaccines are becoming available and are free for everyone in the United States. […] A person can protect themselves and prevent the spread of COVID-19 by following these guidelines: […] Get vaccinated as soon as the vaccine becomes available. […] Vaccines are starting to become available. Here, learn more about vaccines that offer protection from COVID-19. […] Meanwhile, continue with physical distancing, frequent hand washing, avoiding touching the face, and wearing a face-covering in public.

• #92 COVID-19: Symptoms, incubation, prevention, and more

  https://www.medicalnewstoday.com/articles/covid-19

  COVID-19 is a highly contagious disease that results from an infection with the virus SARS-CoV-2, a type of coronavirus. […] Even if a person has no symptoms, they can pass the infection to others. It is vital to take steps to prevent this. […] To prevent the illness, take precautions, such as washing the hands frequently, wearing a face-covering in public, and staying away from others. Isolating is especially crucial for people who feel ill. […] Vaccines are becoming available and are free for everyone in the United States. […] A person can protect themselves and prevent the spread of COVID-19 by following these guidelines: […] Get vaccinated as soon as the vaccine becomes available. […] Vaccines are starting to become available. Here, learn more about vaccines that offer protection from COVID-19. […] Meanwhile, continue with physical distancing, frequent hand washing, avoiding touching the face, and wearing a face-covering in public.

• #93

  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines

  All COVID-19 vaccines, listed by WHO as for emergency use or prequalified, provide protection against severe disease and death resulting from COVID-19 infection. […] For optimal protection, it is important to receive the recommended COVID-19 vaccine doses. Consult with your health care provider for specific advice. […] Revaccination is recommended 6 to 12 months after the last dose for high-risk persons including older adults, individuals with chronic and/or immunocompromised conditions and health workers with direct patient contact. Revaccination during each pregnancy is recommended. […] Vaccination is recommended for those who have never received any COVID-19 vaccine and are at high risk of severe illness such as older persons, adults with chronic diseases, individuals with immunocompromising conditions and health workers with direct patient contact. Pregnant persons should get one dose.

• #94

  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines

  Hybrid immunity the immunity one receives from both vaccination and prior COVID-19 infection enhances protection against the severe outcomes of future COVID-19 infections and offers longer protection than infection alone. […] Yes, WHO recommends a single dose of the COVID-19 vaccine during each pregnancy. Pregnant persons are at a higher risk from COVID-19, which can affect both them and the baby. […] Vaccination during pregnancy is safe. It also benefits the baby, as it allows the antibodies created to be passed from mother to child. These antibodies can also help protect the baby for the first few months of life. […] Yes, you should get vaccinated if you are planning to get pregnant. […] There is no evidence that suggests the COVID-19 vaccines interfere with fertility. There is currently no biological evidence that antibodies from COVID-19 vaccination or vaccine ingredients could cause any problems with reproductive organs. […] If you are breastfeeding, you should get vaccinated against COVID-19 with the available vaccine according to your national recommendations.

• #95

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  COVID-19 vaccines are safe. […] Safe and effective vaccines help ensure that COVID-19 does not result in severe disease and death. In 2021 alone, COVID-19 vaccines saved at least an estimated 14.4 million lives worldwide. […] The table below outlines the updated recommendations based on a persons (1) vaccination history and (2) age and health condition. Summary SAGE recommendations for COVID-19 vaccine […] Revaccination approximately 12 months after the previous dose is particularly important for those groups at higher risk of severe disease and mortality (older adults, people with chronic diseases, pregnant persons, immunocompromised persons) and health workers. […] Take whatever vaccine is made available to you, even if you have already had COVID-19. Hybrid immunity (protection from both vaccination and COVID-19 infection) enhances protection against severe disease of future COVID-19 infections and confers longer protection.

• #96 National Organizations in Epidemiology and Infection Prevention Say COVID-19 Vaccines Should be Required for Healthcare Personnel – SHEA

  https://shea-online.org/national-organizations-in-epidemiology-and-infection-prevention-say-covid-19-vaccines-should-be-required-for-healthcare-personnel/

  Hospitals and other healthcare facilities should require employees to be vaccinated against COVID-19, according to a consensus statement by the Society for Healthcare Epidemiology of America (SHEA) and six other leading organizations representing medical professionals working in infectious diseases, infection prevention, pharmacy, pediatrics, and long-term care. […] „The COVID-19 vaccines in use in the United States have been shown to be safe and effective,” said David J. Weber, a member of the SHEA Board of Trustees and lead author of the statement. […] The COVID-19 vaccines authorized for use in the United States have been found safe and effective in preventing infection and reducing transmission. […] „Vaccinating the healthcare workforce reduces the risk of transmission by protecting patients, healthcare personnel, and communities, and maintains trust in healthcare providers and healthcare institutions,” Weber said.

• #97 Coronavirus: Vaccine Information and PlanningIN.gov

  https://www.coronavirus.in.gov/vaccine/

  There are precautions you can take to prevent serious illness from COVID-19. The safe and effective vaccine is the best way to build protection. […] The U.S. Food and Drug Administration (FDA) has approved and authorized an updated Moderna, Pfizer 2024 COVID-19 vaccine. The Centers for Disease Control and Prevention (CDC) also recommends everyone 6 months and older get an updated COVID-19 vaccine to protect against the potentially serious outcomes of COVID-19 illness. […] Adults ages 65 and older can now to receive an additional updated 2024-2025 COVID-19 vaccine dose as long as four months have passed since their last dose. Adults in this age range are at greater risk for severe outcomes of COVID-19, and an additional dose of the updated COVID-19 vaccine may restore protection that has waned since a fall vaccine dose.

• #98

  https://www.nj.gov/health/covid-19/information/vaccines/

  Keeping up to date with your COVID-19 vaccines is the best way to prevent serious illness, protect your community, and stay safe. […] Everyone 6 months and older should get a 2024-2025 COVID-19 vaccine. […] It is especially important for those 65 and older, individuals at high risk of severe COVID-19, or anyone who has never received a COVID-19 vaccine. […] The COVID-19 vaccine helps protect against severe illness, hospitalization, and death. […] Vaccine protection decreases over time, making it essential to stay up to date. […] COVID-19 vaccines have been proven safe and effective. […] Vaccination significantly decreases the chance of severe illness if you contract COVID-19. […] Staying current with vaccinations helps lower the risk of severe outcomes. […] Regular vaccination reduces the likelihood of developing long-term symptoms after infection. […] High vaccination rates make it harder for the virus to spread in communities. […] Unvaccinated individuals remain at risk of severe illness and can more easily spread COVID-19, including to those who can’t receive the vaccine for medical reasons. Protect yourself and others by getting vaccinated.

• #99

  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice

  COVID-19 vaccines are safe. […] Safe and effective vaccines help ensure that COVID-19 does not result in severe disease and death. In 2021 alone, COVID-19 vaccines saved at least an estimated 14.4 million lives worldwide. […] The table below outlines the updated recommendations based on a persons (1) vaccination history and (2) age and health condition. Summary SAGE recommendations for COVID-19 vaccine […] Revaccination approximately 12 months after the previous dose is particularly important for those groups at higher risk of severe disease and mortality (older adults, people with chronic diseases, pregnant persons, immunocompromised persons) and health workers. […] Take whatever vaccine is made available to you, even if you have already had COVID-19. Hybrid immunity (protection from both vaccination and COVID-19 infection) enhances protection against severe disease of future COVID-19 infections and confers longer protection.

• #100

  https://www.nj.gov/health/covid-19/information/vaccines/

  Keeping up to date with your COVID-19 vaccines is the best way to prevent serious illness, protect your community, and stay safe. […] Everyone 6 months and older should get a 2024-2025 COVID-19 vaccine. […] It is especially important for those 65 and older, individuals at high risk of severe COVID-19, or anyone who has never received a COVID-19 vaccine. […] The COVID-19 vaccine helps protect against severe illness, hospitalization, and death. […] Vaccine protection decreases over time, making it essential to stay up to date. […] COVID-19 vaccines have been proven safe and effective. […] Vaccination significantly decreases the chance of severe illness if you contract COVID-19. […] Staying current with vaccinations helps lower the risk of severe outcomes. […] Regular vaccination reduces the likelihood of developing long-term symptoms after infection. […] High vaccination rates make it harder for the virus to spread in communities. […] Unvaccinated individuals remain at risk of severe illness and can more easily spread COVID-19, including to those who can’t receive the vaccine for medical reasons. Protect yourself and others by getting vaccinated.

• #101 Prevention and Recommendations

  https://www.nj.gov/health/covid-19/information/prevention-recommendations/

  Preventing COVID-19 helps protect you, your family, and your community by reducing the spread of the virus and easing the strain on health care systems. […] Vaccines are one of the most effective defenses against severe illness, hospitalization, and death from COVID-19. Stay informed about current vaccine recommendations for optimal protection. […] Learn more about COVID-19 vaccines.

• #102 COVID-19: Symptoms, incubation, prevention, and more

  https://www.medicalnewstoday.com/articles/covid-19

  COVID-19 is a highly contagious disease that results from an infection with the virus SARS-CoV-2, a type of coronavirus. […] Even if a person has no symptoms, they can pass the infection to others. It is vital to take steps to prevent this. […] To prevent the illness, take precautions, such as washing the hands frequently, wearing a face-covering in public, and staying away from others. Isolating is especially crucial for people who feel ill. […] Vaccines are becoming available and are free for everyone in the United States. […] A person can protect themselves and prevent the spread of COVID-19 by following these guidelines: […] Get vaccinated as soon as the vaccine becomes available. […] Vaccines are starting to become available. Here, learn more about vaccines that offer protection from COVID-19. […] Meanwhile, continue with physical distancing, frequent hand washing, avoiding touching the face, and wearing a face-covering in public.

• #103

  https://www.nj.gov/health/covid-19/information/vaccines/

  Keeping up to date with your COVID-19 vaccines is the best way to prevent serious illness, protect your community, and stay safe. […] Everyone 6 months and older should get a 2024-2025 COVID-19 vaccine. […] It is especially important for those 65 and older, individuals at high risk of severe COVID-19, or anyone who has never received a COVID-19 vaccine. […] The COVID-19 vaccine helps protect against severe illness, hospitalization, and death. […] Vaccine protection decreases over time, making it essential to stay up to date. […] COVID-19 vaccines have been proven safe and effective. […] Vaccination significantly decreases the chance of severe illness if you contract COVID-19. […] Staying current with vaccinations helps lower the risk of severe outcomes. […] Regular vaccination reduces the likelihood of developing long-term symptoms after infection. […] High vaccination rates make it harder for the virus to spread in communities. […] Unvaccinated individuals remain at risk of severe illness and can more easily spread COVID-19, including to those who can’t receive the vaccine for medical reasons. Protect yourself and others by getting vaccinated.

• #104 COVID-19 vaccines never promised perfection. Experts say it’s time to curb our highest expectations | PBS News

  https://www.pbs.org/newshour/health/covid-19-vaccines-never-promised-perfection-experts-say-its-time-to-curb-our-highest-expectations

  The way to make progress in the fight is to get more people vaccinated both here and abroad to cut transmission and the risk of new variants emerging, they insist. […] Giving a booster to vaccinated people is not going to control delta. Whats going to control delta is vaccinating unvaccinated people, Durbin said. […] Edwards, from Vanderbilt, thinks were going to have to curb our expectations, warning that as time goes on, there will likely be vaccinated people who arent immunocompromised who will get severely ill and some will die. […] I think that we have to be realistic about what we can expect.

• #105 Disease Prevention | Pitkin County, CO

  https://www.pitkincounty.com/1175/Disease-Prevention

  Vaccine Preventable Diseases (VPDs) include many highly contagious and deadly pathogens that are easily preventable by staying up to date on routine vaccinations. […] Maintaining high rates of vaccination in the community is essential to protecting individuals from suffering potentially severe negative medical outcomes, including death, due to VPDs. […] On-time vaccination throughout childhood is essential because it helps provide immunity before children are exposed to potentially life-threatening diseases. […] Seasonal vaccinations for Influenza and Covid-19 are the best way to prevent severe negative health outcomes for both of these illnesses. […] Stay up to date on seasonal illness vaccines! Covid-19 and flu vaccines are available for everyone 6 months and older and are especially important for individuals at risk for severe illness. […] Scheduling your seasonal vaccinations for Flu and Covid-19 as well as staying home and wearing masks in public can dramatically reduce the risk of community spread of respiratory illnesses and help protect high risk individuals.

• #106 COVID-19: Symptoms, incubation, prevention, and more

  https://www.medicalnewstoday.com/articles/covid-19

  COVID-19 is a highly contagious disease that results from an infection with the virus SARS-CoV-2, a type of coronavirus. […] Even if a person has no symptoms, they can pass the infection to others. It is vital to take steps to prevent this. […] To prevent the illness, take precautions, such as washing the hands frequently, wearing a face-covering in public, and staying away from others. Isolating is especially crucial for people who feel ill. […] Vaccines are becoming available and are free for everyone in the United States. […] A person can protect themselves and prevent the spread of COVID-19 by following these guidelines: […] Get vaccinated as soon as the vaccine becomes available. […] Vaccines are starting to become available. Here, learn more about vaccines that offer protection from COVID-19. […] Meanwhile, continue with physical distancing, frequent hand washing, avoiding touching the face, and wearing a face-covering in public.

• #107 Coronavirus: Vaccine Information and PlanningIN.gov

  https://www.coronavirus.in.gov/vaccine/

  You can also help protect yourself and others by improving ventilation and following respiratory virus guidance. […] Other measures to help prevent you from breathing in virus particles include wearing a mask or increasing the space from other people. Learn more on about how to protect yourself against infection.

• #108 COVID-19 Vaccine and Prevention – MU Health Care

  https://www.muhealth.org/conditions-treatments/coronavirus/vaccine

  The key to effectively managing coronavirus is vaccination. […] There are three vaccines authorized for use in the United States for the 2024-25 season to prevent COVID-19. Current evidence-based public health guidelines state that everyone 6 months and older should get a 2024-25 COVID-19 vaccination, including those who have received a COVID-19 vaccine before and those who have had COVID-19. Vaccination is the best way to protect yourself from the current variants. […] Everyone ages 6 months and older should get the 20242025 COVID-19 vaccine. The COVID-19 vaccine helps protect against severe disease, hospitalization and death. It is especially important for patients: 65 and older, at high risk for severe COVID-19, and who may have never received a previous COVID-19 vaccine dose. […] If you have already had COVID-19, you still benefit from the vaccine.

• #109 Prevent COVID-19 | American Lung Association

  https://www.lung.org/lung-health-diseases/lung-disease-lookup/covid-19/prevention

  We are all at risk for getting and spreading COVID-19. There are steps you can take to prevent yourself and others from getting sick, starting with an updated COVID-19 vaccination. […] COVID-19 vaccines help protect you from getting seriously ill from COVID-19 by helping your body develop protection from the virus that causes COVID-19. Updated COVID-19 vaccines from Pfizer-BioNTech and Moderna are available for the 2024-25 fall and winter virus season for everyone 6 months and older. Updated COVID-19 vaccines from Novavax are available for everyone 12 years and older. […] COVID-19 vaccines are the best option for preventing COVID-19 illness, hospitalizations and death. Pledge to get yours today! […] COVID-19 vaccines are the best protection available against serious illness, hospitalization and death. Here are some more facts you should know: COVID-19 vaccines help our bodies develop immunity against the virus that causes COVID-19. […] Getting a COVID-19 vaccine is a safer way to build immunity to COVID-19 than getting sick with the disease.

• #110 COVID-19 Resource Center

  https://www.healio.com/news/infectious-disease/20240821/experts-recommend-covid19-prevention-drug-for-immunocompromised-patients

  The Infectious Diseases Society of America has suggested providing a COVID-19 prevention drug to immunocompromised patients. […] In new guidance, the Infectious Diseases Society of America suggested that immunocompromised patients take the monoclonal antibody pemivibart as pre-exposure prophylaxis to prevent severe COVID-19. […] The anticipated benefit is likely greatest in people who are the most immunocompromised because they have the highest risk of inadequate immune response and progression to severe disease, the authors of the new guidance wrote. […] In March, the FDA authorized pemivibart for emergency use in moderately or severely immunocompromised patients aged 12 years or older who are not infected with SARS-CoV-2 and have not been recently exposed to someone with the virus. It is the only FDA-approved medicine for COVID-19 PrEP. […] The IDSAs suggestion was based on pemivibarts demonstrated ability to protect against omicron subvariants of SARS-CoV-2, but Bhimraj and colleagues noted that the emergence of new subvariants could impact its effectiveness.

• #111 COVID-19 Vaccines, Pre-Exposure Prophylaxis, and Treatment for Non-Hospitalized Patients | Department of Health and Human Services

  http://www.maine.gov/dhhs/oms/providers/provider-bulletins/covid-19-vaccines-pre-exposure-prophylaxis-and-treatment-non-hospitalized-patients-2022-05

  COVID-19 vaccination remains the best way to prevent infection, hospitalization, and death. […] Patients who are moderately or severely immunocompromised should receive additional vaccine doses and may also receive pre-exposure prophylaxis to further reduce the risk of infection, hospitalization, and death. […] Pre-exposure prophylaxis is now available for certain individuals who have been vaccinated against COVID-19 and remain highly susceptible to infection and severe disease.

• #112 Vaccines | Covid-19

  http://www.maine.gov/covid19/vaccines

  COVID-19 vaccines are safe and effective at preventing severe illness, hospitalization and death. For the best protection, everyone 6 months and older should stay up to date with their COVID-19 vaccines. […] Updated COVID-19 vaccines are recommended for everyone 6 months and older. […] Getting the COVID-19 vaccine will help keep you healthy and help slow the spread of the virus.

• #113 COVID-19 Resource Center

  https://www.healio.com/news/infectious-disease/20240821/experts-recommend-covid19-prevention-drug-for-immunocompromised-patients

  The Infectious Diseases Society of America has suggested providing a COVID-19 prevention drug to immunocompromised patients. […] In new guidance, the Infectious Diseases Society of America suggested that immunocompromised patients take the monoclonal antibody pemivibart as pre-exposure prophylaxis to prevent severe COVID-19. […] The anticipated benefit is likely greatest in people who are the most immunocompromised because they have the highest risk of inadequate immune response and progression to severe disease, the authors of the new guidance wrote. […] In March, the FDA authorized pemivibart for emergency use in moderately or severely immunocompromised patients aged 12 years or older who are not infected with SARS-CoV-2 and have not been recently exposed to someone with the virus. It is the only FDA-approved medicine for COVID-19 PrEP. […] The IDSAs suggestion was based on pemivibarts demonstrated ability to protect against omicron subvariants of SARS-CoV-2, but Bhimraj and colleagues noted that the emergence of new subvariants could impact its effectiveness.

• #114 Coronavirus: Vaccine Information and PlanningIN.gov

  https://www.coronavirus.in.gov/vaccine/

  You can also help protect yourself and others by improving ventilation and following respiratory virus guidance. […] Other measures to help prevent you from breathing in virus particles include wearing a mask or increasing the space from other people. Learn more on about how to protect yourself against infection.

• #115 COVID-19 vaccine | Colorado Department of Public Health and Environment

  https://cdphe.colorado.gov/covid-19/vaccine

  Getting vaccinated against COVID-19 is the safest, easiest way to lower your risk of serious illness, Long COVID, hospitalization, and death. Everyone aged 6 months and older is recommended to stay up to date with COVID-19 vaccines. […] Everyone aged 6 months and older should get a 2024-2025 COVID-19 vaccine. Most people only need one dose of the updated vaccine. Its safe to get your COVID-19 vaccine and flu vaccine at the same appointment. […] Talking with a health care provider can help you learn more about how many doses you or your child needs and when to schedule them. However, a conversation with a health care provider is not required to get vaccinated. […] If you dont have insurance, or your insurance doesnt cover COVID-19 vaccines, you can still get vaccinated at low or no cost. […] A Colorado law called Individual Access to Publicly Funded Vaccines helps make sure people can get the COVID-19 vaccine even if they dont have health insurance or cant afford to pay a fee.

• #116 Early effectiveness of the BNT162b2 KP.2 vaccine against COVID-19 in the US Veterans Affairs Healthcare System | Nature Communications

  https://www.nature.com/articles/s41467-025-59344-7

  In summary, the BNT162b2 KP.2 vaccine was 5668% effective at preventing a range of COVID-19 outcomes during the early part of the 20242025 respiratory virus season. Maintaining protection against COVID-19 with vaccination continues to be critical given that the post-pandemic burden of COVID-19 remains substantial.

Zobacz więcej